Effect of tumor necrosis factor α - on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process

Journal of Experimental Medicine

Volumn 180, Issue 3, 1994, Pages 995-1004

  Yang, Xiao Dong ^a   Tisch, Roland ^a   Singer, Steven M ^a,d   Cao, Zhu A ^a   Liblau, Roland S ^a   Schreiber, Robert D ^b   Mc Devitt, Hugh O ^c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; DIABETOGENESIS; FEMALE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AGE FACTORS; ANIMAL; ANTIBODIES, MONOCLONAL; AUTOIMMUNITY; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR;

EID: 0027990811     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.180.3.995     Document Type: Article

References (55)

1. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF—a primary mediator of the host response. Annu. Rev. Immunol. 7:625.
2. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
3. Powrie, F., and R.L. Coffman. 1993. Cytokine regulation of T cell function: potential for therapeutic intervention. Immunol. Today. 14:270.
4. Tartaglia, L.A., and D.V. Goeddel. 1992. Two TNF receptors. Immunol. Today 13:151.
5. Held, W., H.R. MacDonald, I.L. Weissman, M.W. Hess, and C. Mueller. 1990. Genes encoding tumor necrosis factor a and granzyme A are expressed during development of autoimmune diabetes. Proc. Natl. Acad. Sei. USA. 87:2239.
6. Pukel, C., H. Baquerizo, and A. Rabinovitch. 1988. Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-7, tumor necrosis factor, lymphotoxin, and interleukin-1. Diabetes. 37:133.
7. Eizirik, D.L. 1988. Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor. Acta Endocrinol. (Copenhagen). 119:321.
8. Rabinovitch, A., H. Baquerizo, C. Pukel, and W. Sumoski. 1989. Effects of cytokines on rat pancreatic islet cell monolayer cultures: distinction between functional and cytotoxic effects on islet j3-cells. Reg. Immunol. 2:77.
9. Campbell, I.L., A. Iscaro, and L.C. Harrison. 1988. IFN-γ and tumor necrosis factor-a. cytotoxicity to murine islets of Langerhans. J. Immunol. 141:2325.
10. Higuchi, Y., P. Herrera, P. Muniesa, J. Huarte, D. Belin, P. Ohashi, P. Aichele, L. Orci, J.-D. Vassalli, and P. Vassalli. 1992. Expression of a tumor necrosis factor a transgene in murine pancreatic β cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. 176:1719.
11. Picarella, D.E., A. Kratz, C. Li, N.H. Ruddle, and R.A. Flavell. 1993. Transgenic tumor necrosis factor (TNF)-a production in pancreatic islets leads to insulitis, not diabetes. J. Immunol. 150:4136.
12. Jacob, C.O., S. Aiso, S.A. Michie, H.O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-a and interleukin 1. Proc. Natl. Acad. Sei. USA. 87:968.
13. Jacob, C.O., and H.O. McDevitt. 1988. Tumor necrosis factor-a in murine autoimmune “lupus” nephritis. Nature (Lond.). 331:356.
14. Lapchak, P.H., L.J. Guilbert, and A. Rabinovitch. 1992. Tumor necrosis factor production is deficient in diabetes-prone BB rats and can be corrected by complete Freund’s adjuvant: a possible immunoregulatory role of tumor necrosis factor in the prevention of diabetes. Clin. Immunol, lmmunopathol. 65:129.
15. Satoh, J., H. Seino, T. Abo, S.-I. Tanaka, S. Shintani, S. Ohta, K. Tamura, T. Sawai, and T. Nobunaga, T. Oteki, et al. 1989. Recombinant human tumor necrosis factor a suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 84:1345.
16. Gordon, C., G.E. Ranges, J.S. Greenspan, and D. Wofsy. 1989. Chronic therapy with recombinant tumor necrosis factor-ct in autoimmune NZB/NZW FI mice. Clin. Immunol. Im-munopathol. 52:421.
17. Giroir, B.P., T. Brown, and B. Beutler. 1992. Constitutive synthesis of tumor necrosis factor in the thymus. Proc. Natl. Acad. Sei. USA. 89:4864.
18. De Kossodo, S., G.E. Grau, T. Daneva, P. Pointarie, L. Fos-sati, C. Ody, J. Zapf, P.-F. Piguet, R.C. Gaillard, and P. Vassalli. 1992. Tumor necrosis factor a is involved in mouse growth and lymphoid tissue development. J. Exp. Med. 176:1259.
19. Yang, X.-D., R. Tisch, Z.A. Cao, S. Singer, R. Schreiber, and H.O. McDevitt. 1993. The role of tumor necrosis factor-a in the development of autoimmunity in NOD mice. Autoimmunity. 15(Suppl.):42.(Abstr.)
20. Sheehan, K.C.F., N.H. Ruddle, and R.D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J. Immunol. 142:3884.
21. Van Der Meide, P.H.M., D.K. Vijerberg, T. Kos, and H. Schellekens. 1986. The purification and characterization of rat gamma interferon by use of two monoclonal antibodies. J. Gen. Virol. 67:1059.
22. Tisch, R., X.-D. Yang, S.M. Singer, R.S. Liblau, L. Fugger, and H.O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature (Lond.). 366:72.
23. Wicker, L., B.J. Miller, and Y. Mullen. 1986. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes. 35:855.
24. Boitard, C., A. Bendelac, M.F. Richard, C. Carnaud, and J.F. Bach. 1988. Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells. Proc. Natl. Acad. Sei. USA. 85:9719.
25. Hanninen, A., C. Taylor, P.R. Streeter, L.S. Stark, J.M. Sarte, J.A. Shizuru, O. Simell, and S.A. Michie. 1993. Vascular ad-dressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J. Clin. Invest. 92:2509.
26. Ogawa, M.T., T. Maruyama, T. Hasegawa, T. Kanaya, J. Kobayashi, Y. Tochino, and H. Uda. 1985. The inhibitory effect of neonatal thymectomy on the incidence of insulitis in NOD mice. Biomedical. Res. 6:103.
27. Dardenne, M., J. Lepault, A. Bendelac, and J.F. Bach. 1989. Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur. J. Immunol. 19:889.
28. Bach, J.F., C. Boitard, R. Yasunami, and M. Dardenne. 1990. Control of diabetes in NOD mice by suppressor cells. J. Autoimmun. 3(Suppl. 1):97.
29. Leiter, E.H., and D.V. Serreze. 1993. Antigen presenting cells and the immunogenetics of autoimmune diabetes in NOD mice. Reg. Immunol. 4:263.
30. Katz, J.D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell. 74:1089.
31. Ranges, G.E., A. Zlotnik, T. Espevik, C.A. Dinarello, A. Cerami, and M.A. Palladino, Jr. 1988. Tumor necrosis factor a/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines. J. Exp Med. 167:1472.
32. Suda, T., R. Murray, M. Fischer, T. Yokota, and A. Zlotnik. 1990. Tumor necrosis factor-a and P40 induce day 15 murine fetal thymocyte proliferation in combination with IL-2.J. Immunol. 144:1783.
33. Defresne, M., C. Humblet, A. Rongy, R. Greimers, and J. Boniver. 1990. Effect of interferon-y and tumor necrosis factor-a on lymphoepithelial interactions within thymic nurse cells. Eur. J. Immunol. 20:429.
34. De Togni, P.D., J. Goellner, N.H. Ruddle, P.R. Streeter, A. Fick, S. Mariathasan, S.C. Smith, R. Carlson, L.P. Shornick, J. Strauss-Schoenberger, et al. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science (Wish. DC). 264:703.
35. Pfeffer, K., T. Matsuyama, T.M. Kuendig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P.S. Ohashi, M. Kroenke, and T.W. Mak. 1993. Mice deficient for the 55kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73:457.
36. Lee, K.-U., K. Amano, and J.-W. Yoon. 1988. Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes. 37:989.
37. Hutchings, P., H. Rosen, L. O’Reilly, E. Simpson, S. Gordon, and A. Cooke. 1990. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature (Lond.). 348:639.
38. Harrison, L.C., I.L. Campbell, J. Allison, and J.F.A.P. Miller. 1989. MHC molecules and β-cell destruction: immune and nonimmune mechanisms. Diabetes. 38:815.
39. +T-lymphocytes. Diabetes. 37:1108.
40. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of Thl cells. Immunol. Today. 14:335.
41. Liblau, R., B. Scott, S. Degermann, L.A. Marconi, L. Ogata, A.J. Caton, H.O. McDevitt, and D. Lo. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity. 1:73.
42. Doukas, J., and J.S. Pober. 1990. IFN-y enhances endothelial activation induced by tumor necrosis factor but not IL-1. J. Immunol. 145:1727.
43. Osborn, L. 1990. Leukocyte adhesion to endothelium in inflammation. Cell. 62:3.
44. Yang, X.-D., N. Karin, R. Tisch, L. Steinman, and H.O. McDevitt. 1993. Inhibition of insulitis and prevention of diabetes in NOD mice by blocking L-selectin and VLA-4 adhesion receptors. Proc. Natl. Acad. Sei. USA. 90:10494.
45. Ruddle, N.H., C.M. Bergman, K.M. McGrath, E.G. Lingen-held, M.L. Grunnet, S.J. Padula, and R.B. Clark. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1193.
46. Williams, R.O., M. Feldman, and R.N. Maini. 1992. Antitumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl. Acad. Set. USA. 89:9784.
47. Feldman, M., F.M. Brennan, R.O. Williams, A.P. Cope, D.L. Gibbons, P.D. Katsikis, and R.N. Maini. 1992. Evaluation of the role of cytokines in autoimmune disease: the importance of TNF-ce in rheumatoid arthritis. Prog. Growth Factor Res. 4:247.
48. Patton, J.S., P.M. Peters, J. McCabe, D. Crase, S. Hansen, A.B. Chen, and D. Liggitt. 1987. Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-a in rodents. J. Clin. Invest. 80:1587.
49. Fraker, D.L., M.C. Stovroff, M.J. Merino, and J.A. Norton. 1988. Tolerance to tumor necrosis factor in rats and the relationships to endotoxin tolerance and toxicity. J. Exp. Med. 168:95.
50. Bendtzen, K., M. Svenson, A. Fomsgaard, L.K. Poulsen, and M.B. Hansen. 1990. Auto-antibodies to IL-1 a and TNF-a in normal individuals and in infectious and immunoinflamma-tory disorders. Prog. Leukocyte Biol. 10B:447.
51. Bendtzen, K., M. Svenson, V. Jonsson, and E. Hippe. 1990. Autoantibodies to cytokines —friends or foes? Immunol. Today. 11:167.
52. Hansen, M.B., M. Svenson, M. Diamant, and K. Bendtzen. 1993. High-afhnity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro. Cytokine. 5:72.
53. Suzuki, H., J. Kamimura, T. Ayabe, and H. Kashiwagi. 1990. Demonstration of neutralizing autoantibodies against IL-1 a in sera from patients with rheumatoid arthritis. J. Immunol. 145:2140.
54. Bemelmans, M.H., DJ. Gouma, and W.A. Buurman. 1993. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma. J. Immunol. 151:5554.
55. Jacob, C.O., S. Aiso, R.D. Schreiber, and H.O. McDevitt. 1992. Monoclonal anti-tumor necrosis factor antibody renders nonobese diabetic mice hypersensitive to irradiation and enhances insulitis development. Int. Immunol. 4:611.